The DOI matches its Crossref record; 182 of the 184 references it cites were found in a registry or an index.
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Abstract
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A member of its family, the JAK2/STAT3 signal pathway, is involved in neuronal death and nervous reorganization in ischemic encephalopathy [62].”
Citations
Cites
1 retracted
Ling, L., Zhang, S., Zhi, L.-D., Li, H., Wen, Q.-K., Li, G., & Zhang, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.042 · Cited by 31
RetractedSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Epidemiology of Parkinson’s disease
Tysnes, O., & Storstein, A. M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,437
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Research works printed but not linked: 3
- Seif, 2017, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells, Cell Commun. Sign., 15, 1
- Oshea, 2015, The JAK-STAT pathway: impact on human disease and therapeutic intervention*, Annu. Rev. Med., 66, 311, 10.1146/annurev-med-051113-024537 · DOI
- Yan, 2018, Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases, Clin. Immunol., 189, 4, 10.1016/j.clim.2016.09.014 · DOI · Paper page
Cited by
Sorted by citations
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 882
Self-citationEvolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Chen, X., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 797
Liu, J., Han, X., Zhang, T., Tian, K., Li, Z., & Luo, F. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01512-7 · Cited by 742
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 715
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 591
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z., Yi, X., Wei, X., & Jiang, D. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05716-0 · Cited by 626
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 540
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Işık, S., Yeman-Kıyak, B., Akbayır, R., Şeyhali-Abutayeh, R., & Arpaci, T. (2023) · Cells · doi:10.3390/cells12071012 · Cited by 419
Mokrá, D., Jošková, M., & Mokrý, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010340 · Cited by 386
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.-S., Zeng, J., Mei, J., & Wang, P. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1110765 · Cited by 387
Liao, H., Ye, J., Gao, L., & Liu, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110917 · Cited by 348
Wang, L., & He, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967193 · Cited by 334
Xiong, Y., Mi, B., Lin, Z., Hu, Y., Yu, L., Zha, K., Panayi, A. C., Yu, T., Chen, L., Liu, Z.-P., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00426-8 · Cited by 304
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Self-citationNeutrophil diversity and function in health and disease
Zhang, F., Xia, Y., Su, J., Quan, F., Zhou, H., Li, Q., Feng, Q., Lin, C., Wang, D., & Jiang, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02049-y · Cited by 306
Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer
Alipour, M. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00518-5 · Cited by 247
Ge, P., Luo, Y., Okoye, C. S., Chen, H., Liu, J., Zhang, G., Xu, C., & Chen, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110770 · Cited by 247
Sarapultsev, A., Gusev, E., Komelkova, M. V., Utepova, I. A., Luo, S., & Hu, D. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00151-1 · Cited by 254
Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis
Liu, S., Ma, H., Zhang, H., Deng, C., & Xin, P. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108793 · Cited by 219
Self-citationRah, B., Rather, R. A., Bhat, G. R., Baba, A. B., Mushtaq, I., Farooq, M., Yousuf, T., Dar, S. B., Parveen, S., Hassan, R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.821344 · Cited by 202
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958790 · Cited by 164
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Audu, C. O., Melvin, W. J., Joshi, A., Wolf, S., Moon, J. Y., Davis, F. M., Barrett, E. C., Mangum, K. D., Deng, H., Xing, X., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00919-5 · Cited by 163
Microglial activation states and their implications for Alzheimer's Disease
Valiukas, Z., Tangalakis, K., Apostolopoulos, V., & Feehan, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100013 · Cited by 167
Molecular mechanism of the anti-inflammatory effects of plant essential oils: A systematic review
Zhao, Q., Zhu, L.-Y., Wang, S., Gao, Y., & Jin, F. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115829 · Cited by 145
Jonscher, K. R., Chowanadisai, W., & Rucker, R. B. (2021) · Biomolecules · doi:10.3390/biom11101441 · Cited by 128
Inflammatory response of nanoparticles: Mechanisms, consequences, and strategies for mitigation
Summer, M., Ashraf, R., Ali, S., Bach, H., Noor, S., Noor, Q., Riaz, S., & Khan, R. R. M. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142826 · Cited by 127
Targeting inflammation as cancer therapy
Wang, M., Chen, S., He, X., Yuan, Y., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01528-7 · Cited by 126
The role of Janus kinase signaling in the pathology of atopic dermatitis
Guttman‐Yassky, E., Irvine, A. D., Brunner, P. M., Kim, B., Boguniewicz, M., Parmentier, J. M., Platt, A. M., & Kabashima, K. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.010 · Cited by 118
Targeting STAT3 Signaling Pathway in Colorectal Cancer
Gargalionis, A. N., Papavassiliou, K. A., & Papavassiliou, A. G. (2021) · Biomedicines · doi:10.3390/biomedicines9081016 · Cited by 115
Xiao, S., Zhang, Y., Liu, Z., Li, A., Tong, W., Xiong, X., Nie, J., Zhong, N., Zhu, G., Liu, J., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14085 · Cited by 118
Beltrán-Velasco, A. I., & Clemente‐Suárez, V. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062440 · Cited by 121
Toader, C., Tătaru, C. P., Munteanu, O., Șerban, M., Covache-Busuioc, R.-A., Ciurea, A. V., & Enyedi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312613 · Cited by 112
Jeon, S., Jeon, Y., Lim, J.-Y., Kim, Y., Cha, B., & Kim, W. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02070-1 · Cited by 105
Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment
Javed, Z., Sadia, H., Iqbal, M. J., Shamas, S., Malik, K. A., Ahmed, R., Raza, S., Butnariu, M., Martins, N. A., & Sharifi‐Rad, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01888-x · Cited by 100
From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders
Hussain, M. S., Gupta, G., Goyal, A., Thapa, R., Almalki, W. H., Kazmi, I., Alzarea, S. I., Fuloria, S., Meenakshi, D. U., Jakhmola, V., et al. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23482 · Cited by 99
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Zhai, Y., Wang, T., Fu, Y., Yu, T., Ding, Y. P., & Nie, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098011 · Cited by 98
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024) · MedComm · doi:10.1002/mco2.497 · Cited by 111
Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases
Xu, J., Cao, K., Liu, X., Zhao, L., Feng, Z., & Liu, J. (2021) · Antioxidants · doi:10.3390/antiox11010029 · Cited by 97
Oxidative Stress in Intestinal Ischemia-Reperfusion
Li, G., Wang, S., & Fan, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.750731 · Cited by 92
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Lashgari, N., Roudsari, N. M., Momtaz, S., Sathyapalan, T., Abdolghaffari, A. H., & Sahebkar, A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577758 · Cited by 90
Xu, Y., Li, Y., Wang, C., Han, T., Liu, H., Sun, L., Hong, J., Hashimoto, M., & Wei, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02723-y · Cited by 90
tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB
Xu, R., Du, A., Deng, X., Du, W., Zhang, K., Li, J., Lu, Y., Wei, X., Yang, Q., & Tang, H. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03132-6 · Cited by 88
Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer
Marković, I., & Savvides, S. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01557 · Cited by 86
The Dysregulation of Inflammatory Pathways Triggered by Copper Exposure
Deng, H., Zhu, S., Yang, H., Cui, H., Guo, H., Deng, J., Ren, Z., Geng, Y., Ouyang, P., Xu, Z., et al. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03171-0 · Cited by 90
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
Yin, Q., Wang, L., Yu, H., Chen, D., Zhu, W., & Sun, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716672 · Cited by 86
Reactive gliosis in traumatic brain injury: a comprehensive review
Amlerova, Z., Chmelová, M., Anděrová, M., & Vargová, L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1335849 · Cited by 89
Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome
Baghdassarian, H., Blackstone, S. A., Clay, G. M., Philips, R. L., Matthíasardóttir, B., Nehrebecky, M. E., Hua, V. K., McVicar, R. N., Liu, Y., Tucker, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2202318 · Cited by 83
The potential roles of JAK/STAT signaling in the progression of osteoarthritis
Zhou, Q., Ren, Q., Jiao, L., Huang, J., Yi, J., Chen, J., Lai, J., Ji, G., & Zheng, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1069057 · Cited by 88
Abid, R., Ghazanfar, S., Farid, A., Sulaman, S. M., Idrees, M., Amen, R. A., Muzammal, M., Shahzad, M. K., Mohamed, M. O., Khaled, A. A., et al. (2022) · Molecules · doi:10.3390/molecules27134304 · Cited by 86
Feng, L., Zheng, Y., Zhao, C., Li, L., Hu, Y., Wang, C., Wang, R., Feng, T., Liu, X., Cui, J., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c16085 · Cited by 78
Ferroptosis: an important player in the inflammatory response in diabetic nephropathy
Li, J., Li, L., Zhang, Z., Chen, P., Shu, H., Yang, C., Chu, Y., & Liu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1294317 · Cited by 82
Pharmacological Effects of Centella asiatica on Skin Diseases: Evidence and Possible Mechanisms
Park, K. S. (2021) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2021/5462633 · Cited by 79
Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals
Li, Y., Ren, X., Zhang, L., Wang, Y., & Chen, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.901117 · Cited by 77
Self-citationYang, Y., Luo, D., Shao, Y. W., Shan, Z., Liu, Q., Weng, J., He, W., Zhang, R., Li, Q., Wang, Z., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12380 · Cited by 78
Ma, H., Wang, C., Han, L., Kong, F., Liu, Z., Zhang, B., Chu, W., Wang, H., Wang, L., Li, Q., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84564 · Cited by 77
Self-citationNatural withanolides, an update
Xia, G., Cao, S., Chen, L., & Qiu, F. (2021) · Natural Product Reports · doi:10.1039/d1np00055a · Cited by 73
Cao, J., Chen, X., Chen, L., Lu, Y., Wu, Y., Deng, A., Pan, F., Huang, H., Liu, Y., Li, Y.-C., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103788 · Cited by 90
Role of the JAK-STAT Pathway in Bovine Mastitis and Milk Production
Khan, M. Z., Khan, A. A., Xiao, J., Ma, Y., Ma, J., Gao, J., & Cao, Z. (2020) · Animals · doi:10.3390/ani10112107 · Cited by 76
Xiao, J., Sun, F., Wang, Y., Лю, Б., Zhou, P., Wang, F., Zhou, H., Ge, Y., Yue, T., Luo, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci158352 · Cited by 69
Self-citationSławińska, N., & Krupa, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020590 · Cited by 68
Regulation of the JAK/STAT signaling pathway: The promising targets for cardiovascular disease
Pang, Q., You, L., Meng, X., Li, Y., Deng, T., Li, D., & Zhu, B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115587 · Cited by 75
Wang, Y., Li, Q.-M., Zha, X., & Luo, J. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.208 · Cited by 70
Self-citationJAK/STAT in leukemia: a clinical update
Liang, D., Wang, Q.-L., Zhang, W., Tang, H., Song, C., Yan, Z., Liang, Y., & Wang, H. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01929-1 · Cited by 82
Gago, C., Serralheiro, A., & Miguel, M. G. (2025) · Molecules · doi:10.3390/molecules30112450 · Cited by 77
Welcome, M. O., & Mastorakis, N. E. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00806-x · Cited by 66
A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms
Xiong, F., Zhang, Y., Li, T., Tang, Y., Song, S., Zhou, Q., & Wang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1389179 · Cited by 68
Self-citationDinakar, Y. H., Kumar, H., Mudavath, S. L., Jain, R., AJMEER, R., & Jain, V. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120996 · Cited by 65
Sadeghi, E., Imenshahidi, M., & Hosseinzadeh, H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08363-y · Cited by 63
Besednova, N. N., Andryukov, B. G., Zaporozhets, T. S., Kuznetsova, T. A., Kryzhanovsky, S. P., Ermakova, S. P., Galkina, I. V., & Shchelkanov, M. Y. (2022) · Marine Drugs · doi:10.3390/md20040243 · Cited by 67
Targeting breast cancer stem cells through retinoids: A new hope for treatment
Jan, N., Sofi, S., Qayoom, H., Haq, B. U., Shabir, A., & Mir, M. A. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104156 · Cited by 62
Kooshki, L., Zarneshan, S. N., Fakhri, S., Moradi, S. Z., & Echeverría, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154686 · Cited by 66
JAK inhibitors (JAKi): Mechanisms of action and perspectives in systemic and autoimmune diseases
Chikhoune, L., Poggi, C., Moreau, J., Dubucquoi, S., HACHULLA, E., Collet, A., & Launay, D. (2024) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2024.10.452 · Cited by 61
Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system
Zhao, L., Hou, C., & Yan, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059947 · Cited by 65
Oxidative stress as a culprit in diabetic kidney disease
Su, S., Ma, Z., Wu, H., Xu, Z., & Yi, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121661 · Cited by 62
miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses
Doghish, A. S., Elballal, M. S., Elazazy, O. E., Elesawy, A. E., Shahin, R. K., Midan, H. M., Sallam, A.-A. M., Elbadry, A. M. M., Mohamed, A. K. I., Ishak, N. W., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154440 · Cited by 60
Immunometabolism in the pathogenesis of asthma
Qin, Z., Chen, Y., Wang, Y., Xu, Y., Liu, T., Mu, Q., & Huang, C. (2023) · Immunology · doi:10.1111/imm.13688 · Cited by 66
Self-citationPark, H., Lee, S.-H., Lee, J., Moon, H., & Ro, S. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813764 · Cited by 63
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., & Du, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1336102 · Cited by 68
Zhou, H., Zhao, C., Wang, P., Yang, W., Zhu, H., & Zhang, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1107182 · Cited by 59
Lee, H., Kwon, Y., Seo, E., Kim, S., Lee, H., Lee, J.-T., Chang, P., Choi, Y. J., Lee, S. H., & Ye, S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116851 · Cited by 66
Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment
Tang, H., Yonghong, P., Yu-feng, Z., & Haitao, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.018 · Cited by 63
Liu, Y., Huang, J., Li, S., Li, Z., Chen, C., Qu, G., Chen, K., Teng, Y., Ma, R., Wu, X., et al. (2023) · Biomaterials Science · doi:10.1039/d3bm01645e · Cited by 61
Akter, K., Gul, K., & Mumtaz, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090716 · Cited by 67
Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance
Wang, X., Lee, J., & Xie, C. (2022) · Cancers · doi:10.3390/cancers14020381 · Cited by 53
Yang, X.-F., & Shang, D. (2023) · Cell Biology International · doi:10.1002/cbin.12065 · Cited by 54
A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid
Cao, Q., Wang, Q., Wu, X., Zhang, Q., Huang, J., Chen, Y., You, Y., Qiang, Y., Huang, X., Qin, R., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1272546 · Cited by 53
Chen, S., Zeng, J., Li, R., Zhang, Y., Tao, Y., Hou, Y., Lu, Y., Zhang, Y., Wu, J., & Meng, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117838 · Cited by 56
Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
Wang, X., Sun, B. T., Wang, Y., Gao, P., Song, J., Chang, W., Xiao, Z., Xi, Y., Li, Z., An, F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1333993 · Cited by 56
Self-citationJanus kinase inhibitors for the treatment of COVID-19
Kramer, A., Prinz, C., Fichtner, F., Fischer, A.-L., Thieme, V., Grundeis, F., Spagl, M., Seeber, C., Piechotta, V., Metzendorf, M., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015209 · Cited by 52
Thyroid hormones act as modulators of inflammation through their nuclear receptors
Lasa, M., & Contreras‐Jurado, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.937099 · Cited by 56
Brain–immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders
Zhao, F., Li, B., Yang, W., Ge, T., & Cui, R. (2022) · Cell Proliferation · doi:10.1111/cpr.13295 · Cited by 50
Chen, J., Shen, B., & Jiang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.978558 · Cited by 52
Khan, M. Z., Wang, J., Ma, Y., Chen, T., Ma, M., Ullah, Q., Khan, I. M., Khan, A. A., Cao, Z., & Liu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1082144 · Cited by 56
Self-citationJAK-STAT Signaling in Autoimmunity and Cancer
Parveen, S., Fatma, M., Mir, S. S., Dermime, S., & Shahab Uddin, M. S. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s485670 · Cited by 55
CRLF1 and CLCF1 in Development, Health and Disease
Crisponi, L., Buers, I., & Rutsch, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020992 · Cited by 48
Deucravacitinib in the treatment of psoriasis
Estevinho, T., Lé, A. M., & Torres, T. R. (2022) · Journal of Dermatological Treatment · doi:10.1080/09546634.2022.2154122 · Cited by 49
Zhou, Y., Li, M., Lin, S., Zhu, Z., Zhuang, Z., Cui, S., Chen, L., Zhang, R., Wang, X., Shen, B., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07577-1 · Cited by 50
Metadata
- Authors
- Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S.
- Affiliations
- Harbin Medical University (CN)
- China Pharmaceutical University (CN)
- Southeast University (CN)
- Corresponding author
- Sun, Shiqin
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 80
- Pages
- 106210
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3001733563
- Cited by
- 1,010
- References
- 184
- Citations by year
- 2026: 125 · 2025: 229 · 2024: 224 · 2023: 195 · 2022: 160 · 2021: 56 · 2020: 20
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundamental Research Funds for the Central Universities (2018XN-25, JFWLD201904)
- National Natural Science Foundation of China (81903763)
- China Postdoctoral Science Foundation (2019M661312)
- Natural Science Foundation of Heilongjiang Province (YQ2019H005)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- JAK/STAT signaling, JAK inhibitors, STAT proteins, JAK kinases, inflammatory diseases, cancer, immune regulation, signaling crosstalk, cell proliferation and differentiation, apoptosis
- MeSH terms
- Animals, Disease Models, Animal, Humans, Immune System Diseases, Inflammation, Signal Transduction, Cytokines, Protein Kinase Inhibitors, STAT Transcription Factors, Janus Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review